Author

Hsing‐Jien Kung

National Health Research InstitutesORCID 0000-0002-9903-5830Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Anne M. HaegertiD· 2 shared Colin C. CollinsiD· 2 shared Funda SariD· 2 shared Hee Chul ChungiD· 2 shared Martin Edwin GleaveiD· 2 shared Robert H. BelliD· 2 shared Stanislav V. VolikiD· 2 shared Yen‐Yi LiniD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anne M. HaegertORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Longitudinal single-cell RNA sequencing of a neuroendocrine transdifferentiation model reveals transcriptional reprogramming in treatment-induced neuroendocrine prostate cancer

Funda Sar, Hee Chul Chung, Yen‐Yi Lin, Dong Lin, Tunç Morova, Anne M. Haegert, Stanislav V. Volik, Robert H. Bell, Stéphane LeBihan, Doğancan Özturan, Hui Xie, Xin Dong, Rebecca Wu, Jing Li, Hsing‐Jien Kung, , Colin C. Collins

This study uses longitudinal scRNA-seq to track neuroendocrine transdifferentiation in a prostate cancer model, identifying transcriptional changes and key regulators during treatment-induced NEPC progression.

Genome Medicine · Oct 28, 2026Peer-reviewedCancer Biology

Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study

Yen‐Yi Lin, Hamideh Sharifi Noghabi, Stanislav V. Volik, Robert H. Bell, Funda Sar, Anne M. Haegert, Hee Chul Chung, Ladan Fazli, Htoo Zarni Oo, Mads Daugaard, Ming-Han Kuo, Sheng-Chieh Hsu, Eddie L. Imada, Claudio Zanettini, Lúcio Rezende Queiroz, , Colin C. Collins

This study identifies rare germline variants associated with metastatic prostate cancer using an extreme phenotype cohort and validates their functional impact.

medRxiv · Apr 28, 2025 · PreprintGenetic & Genomic Medicine